Journey Medical climbs after quarterly revenue beat
13/08/2026 12:17
BUZZ-Journey Medical climbs after quarterly revenue beat ** Shares of pharmacetical company Journey Medical DERM.O rise 6.7% to $6.86 premarket
** Co's Q2 revenue of $18.5 million beats analysts' average expectation of $18.4 million, according to data compiled by LSEG
** B. Riley analysts say the results strongly support DERM's investment thesis that growth would come from improving volume and average selling price of its products
** Co sells and markets FDA-approved prescription medicines for the treatment of various skin conditions
** Co reports Q2 loss of 1 cent/share vs analysts' average loss estimate of 2 cents/share
** Up to last close, stock down 16.6% YTD
(Reporting by Christy Santhosh)
Recent news on Journey Medical
See all newsJourney Medical Corp expected to post a loss of 1 cent a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
U.S. STOCKS ON THE MOVE-Five Below, Salesforce, IBM, Akamai Technologies